Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the treatment of type 2 diabetes. This therapy works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://prestonpwgq622991.spintheblog.com/39393445/retaglutide-a-promising-glp-1-receptor-agonist